Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/25/2014EP2746251A2 Positively charged water-soluble prodrugs of acetaminophen and related compunds with very fast skin penetration rate
06/25/2014EP2745877A1 Oral care product comprising lactylate
06/25/2014EP2745850A1 Nano-particles for internal radiation therapy of involved area, and therapy system
06/25/2014EP2745849A1 Polydeoxyribonucleotides composition and uses thereof
06/25/2014EP2745847A1 Progestins for preventing or reducing neurodeneration or ischemic damage
06/25/2014EP2745842A2 Anti-cancer composition comprising wnt decoy receptors
06/25/2014EP2745839A1 Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum
06/25/2014EP2745838A1 Prophylactic agent and/or therapeutic agent for sepsis
06/25/2014EP2745837A1 Glomerulonephritis Treatment
06/25/2014EP2745836A1 Topical oral composition for alleviating dry mouth symptoms and for treating mouth ulcers
06/25/2014EP2745708A1 Antidepressant effect of ß-hydroxy-ß-methylbutyrate
06/25/2014EP2745706A1 Methods for maintaining bone quality
06/25/2014EP2745705A1 Nutritional use of human milk oligosaccharides
06/25/2014EP2745692A1 anti-fungal formulation containing luliconazole
06/25/2014EP2744931A1 Soluble polypeptides
06/25/2014EP2744832A2 Matrices comprising a modified polysaccharide
06/25/2014EP2744812A2 Therapeutically active fused pyrimidine derivatives
06/25/2014EP2744811A1 Inhibitors of human immunodeficiency virus replication
06/25/2014EP2744810A1 Tenofovir alafenamide hemifumarate
06/25/2014EP2744809A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
06/25/2014EP2744808A2 Tricyclic compounds as anticancer agents
06/25/2014EP2744807A1 Lysophosphatidic acid receptor antagonists
06/25/2014EP2744806A1 Novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
06/25/2014EP2744805A1 Heteroaryl sodium channel inhibitors
06/25/2014EP2744804A1 Inhibitors of bruton's tyrosine kinase
06/25/2014EP2744803A2 Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors
06/25/2014EP2744798A1 Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease
06/25/2014EP2744797A1 Dyrk1 inhibitors and uses thereof
06/25/2014EP2744787A1 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
06/25/2014EP2744786A1 Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer
06/25/2014EP2744785A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
06/25/2014EP2744784A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
06/25/2014EP2744781A1 Fentanyl derivatives as ph-dependent opioid receptor agonists
06/25/2014EP2744778A2 Meta-substituted biphenyl peripherally restricted faah inhibitors
06/25/2014EP2744777A1 Trans-clomiphene metabolites and uses thereof
06/25/2014EP2744775A1 Bax agonist, compositions, and methods related thereto
06/25/2014EP2744773A1 Fluorinated bisphenol ether compounds and methods for their use
06/25/2014EP2744571A2 Scirpusin a and scirpusin band anti-obesity potential thereof
06/25/2014EP2744502A2 Methods useful in the prevention of hypoxic injury
06/25/2014EP2744501A1 Amino quinazolines as kinase inhibitors
06/25/2014EP2744500A1 Compounds for use in cancer therapy
06/25/2014EP2744499A1 Inhibitors of the renal outer medullary potassium channel
06/25/2014EP2744498A1 N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinoline carboxamide, preparation and uses thereof
06/25/2014EP2744497A2 Therapeutic combinations of netupitant and palonosetron
06/25/2014EP2744496A1 Controlled-release formulation
06/25/2014EP2744495A2 Anthelmintic formulations and treatments
06/25/2014EP2744494A1 Combination cancer therapy of hsp90 inhibitor with antimetabolite
06/25/2014EP2744493A1 Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy
06/25/2014EP2744492A1 Combinations of corroles and statins
06/25/2014EP2744491A1 Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
06/25/2014EP2744490A1 Methods and compositions for increasing growth hormones
06/25/2014EP2744489A1 Process for manufacturing hmb and salts thereof
06/25/2014EP2744488A1 Methods for ameliorating symptoms or conditions caused by stress
06/25/2014EP2744487A2 No- and h2s- releasing compounds
06/25/2014EP2744484A1 Pharmaceutical composition comprising 4-[4[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methylpyridine-2-carboxamide
06/25/2014EP2744483A1 Delivery system for specifically targeting cancer cells and method of use thereof
06/25/2014EP2744479A1 Pharmaceutical aerosol product for administration by oral or nasal inhalation
06/25/2014EP2744474A1 Medicinal skin protection composition with an active ingredient combination which improves the skin barrier
06/25/2014EP2744355A1 Edible composition comprising sterol
06/25/2014EP2744342A1 Therapeutic methods
06/25/2014EP2744338A1 Selective glycosidase inhibitors and uses thereof
06/25/2014EP2744336A1 Process and intermediates for preparing macrolactams
06/25/2014EP2744332A1 Benzofuran compounds for the treatment of hepatitis c virus infections
06/25/2014EP2744331A1 Methods and intermediates for preparing macrolactams
06/25/2014CN1884262B 4-氨基哌啶类化合物及其医药用途 4-amino-piperidine compounds and pharmaceutical use
06/25/2014CN1867322B 结晶形式的γ-氨基丁酸类似物 Crystalline form of γ- aminobutyric acid analogue
06/25/2014CN1646141B 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 For the treatment of viral infections and abnormal cell proliferation modified nucleoside compounds
06/25/2014CN103890246A 可溶性多肽 Soluble polypeptides
06/25/2014CN103889996A 选择性糖苷酶抑制剂及其用途 Selective glycosidase inhibitors and their uses
06/25/2014CN103889993A 修饰的肌酸化合物 Modified creatine compounds
06/25/2014CN103889989A 稠合杂环衍生物及其制药用途 Fused heterocyclic derivatives and pharmaceutical use
06/25/2014CN103889988A Nedd8-活化酶的抑制剂 Nedd8- activating enzyme inhibitor
06/25/2014CN103889987A 作为btk-抑制剂的4-咪唑并哒嗪-1-基-苯甲酰胺类和4-咪唑并三嗪-1-基-苯甲酰胺类 As btk- inhibitor 4-imidazolyl-1-yl and pyridazin - benzamide and 4-triazin-1-yl-imidazo - benzamides
06/25/2014CN103889986A 新杂环衍生物及其应用 New heterocyclic derivatives and its application
06/25/2014CN103889984A 4-(8-甲氧基-1-((1-甲氧基丙烷-2-基)-2-(四氢-2H-吡喃-4-基)-1H-咪唑并[4,5-c]喹啉-7-基)-3,5-二甲基异噁唑及其作为溴结构域抑制剂的用途 4- (8-methoxy-1 - ((1-methoxy-propan-2-yl) -2- (tetrahydro -2H- pyran-4-yl) -1H- imidazo [4,5- c] quinolin-7-yl) -3,5-dimethyl-isoxazole and their use as inhibitors of the use of bromine domain
06/25/2014CN103889983A 新型酶抑制剂化合物 Novel inhibitor compound
06/25/2014CN103889982A 杀微生物的吡唑衍生物 Pyrazole derivative microbial kill
06/25/2014CN103889981A 作为抗癌剂的三环化合物 Tricyclic compounds as anticancer agents
06/25/2014CN103889976A 吲唑化合物、组合物及使用方法 Indazole compounds, compositions and methods of use
06/25/2014CN103889974A 放射性标记的化合物和它们在哺乳动物中作为磷酸二酯酶(pde10a)的定量成像的放射示踪剂的用途 Radiolabeled compounds and their use as phosphodiesterase (pde10a) quantitative imaging radiotracer in a mammal The use
06/25/2014CN103889973A 杂环基酰胺取代的咪唑的磺酸盐 A heterocyclic group substituted-imidazole amide sulfonates
06/25/2014CN103889972A 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物 A phosphodiesterase inhibitor 1-phenyl-2-pyridinyl alkyl alcohols derivatives
06/25/2014CN103889971A (1，l-二氧代-4-硫代吗啉基)-[6-[[3(4-氟苯基)-5-甲基-4-异噁唑基]甲氧基]-3-吡啶]-甲酮的固体形式 (1, l- dioxo-4-thiomorpholinyl) - [6 - [[3 (4-fluorophenyl) -5-methyl-4-isoxazolyl] methoxy] -3 - pyridine] - solid -methanone
06/25/2014CN103889970A 新的哌啶子基-二氢噻吩并嘧啶亚砜及其在治疗copd和哮喘中的用途 New piperidino - dihydro-thieno pyrimidine sulfoxides and their use in the treatment of asthma and copd
06/25/2014CN103889968A 氨基苯并二氢吡喃、氨基苯并二氢噻喃及氨基-1,2,3,4-四氢喹啉衍生物，包含这些化合物的药用组合物，及其在治疗中的用途 Aminochroman, amino thiochromanone and amino-1,2,3,4-tetrahydro-quinoline derivatives, pharmaceutical compositions containing these compounds, and their use in therapy
06/25/2014CN103889965A 杂环羰基氨基噻唑、包含其的化妆或皮肤学制剂及其用于克服和预防不期望的皮肤色素沉着的用途 Heterocyclic-carbonyl-amino-thiazole, which comprises a cosmetic or dermatological formulations for overcoming and preventing its undesirable skin pigmentation purposes
06/25/2014CN103889963A 喹唑啉酮类似物以及喹唑啉酮类似物在用于治疗或预防某些病毒感染中的应用 Quinazolinone analogs and quinazolinone analogs for the treatment or prophylaxis of certain viral infections Application
06/25/2014CN103889962A 作为受体酪氨酸激酶btk抑制剂的取代的n-(3-(嘧啶-4-基)苯基)丙烯酰胺类似物 As receptor tyrosine kinase inhibitors btk substituted n- (3- (pyrimidin-4-yl) phenyl) acrylamide analogues
06/25/2014CN103889961A 作为辣椒素类似物受体配体的携带被含氧基团取代的苯基的被取代的基于吡唑基的甲酰胺及脲衍生物 As the carrying-containing group substituted phenyl group substituted pyrazole group is based on formamide and urea derivatives of capsaicin receptor ligand analogs
06/25/2014CN103889960A 用于防治无脊椎动物害虫的氨基甲酰基甲氧基-和氨基甲酰基甲硫基-及氨基甲酰基甲基氨基苯甲酰胺 For controlling invertebrate pests carbamoyl-methoxy - and the carbamoyl methylthio - and the carbamoyl-methyl-amino-benzamide
06/25/2014CN103889959A 用于防治无脊椎动物害虫的氨基甲酰基甲氧基-和氨基甲酰基甲硫基-及氨基甲酰基甲基氨基苯甲酰胺 For controlling invertebrate pests carbamoyl-methoxy - and the carbamoyl methylthio - and the carbamoyl-methyl-amino-benzamide
06/25/2014CN103889958A 通过新的中间体制备5-(2-{[6-(2,2-二氟-2-苯基乙氧基)己基]氨基}-1(r)-羟基乙基)-8-羟基喹啉-2(1h)-酮的方法 Preparation of 5 via the new intermediate (2 - {[6- (2,2-difluoro-2-phenylethoxy) hexyl] amino} -1 (r) - hydroxyethyl) -8-hydroxy-quinoline morpholine -2 (1h) - ketone
06/25/2014CN103889957A 制备高纯度孟鲁司特钠盐的方法 Preparation of high purity methods of montelukast sodium
06/25/2014CN103889951A 唑类衍生物 Azole derivative
06/25/2014CN103889948A 1-环烷基-或1-杂环基-肟基-3-苯基-丙烷类 1-cycloalkyl - heterocyclyl or 1 - phenyl-3-oxime - propanes
06/25/2014CN103889461A 保护细胞免于alu-rna诱导的变性和用于保护细胞的抑制剂 Protect cells from alu-rna-induced degeneration and inhibitors for protecting cells
06/25/2014CN103889457A 使用特异性的基于壳聚糖的纳米复合物用于有效并安全递送siRNA的组合物和方法 The compositions and methods using specific chitosan-based nanocomposites for efficient delivery of siRNA to secure
06/25/2014CN103889456A 丙烯酸类聚合物制剂 Acrylic polymer formulation
06/25/2014CN103889455A 稳定化乙哌立松医药组成物及含有上述组成物的缓释制剂 Eperisone stabilized pharmaceutical composition containing the composition and sustained-release preparations
06/25/2014CN103889429A Sglt2抑制剂的结晶和非结晶形式 Crystalline and amorphous forms Sglt2 inhibitor
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 7860